Wecare Bifidobacterium animalis subsp. lactis BLa80

Home
Products
Products

We are leaders in microbiome research, with a focus on probiotic strains, starter cultures, and the influence of beneficial microbial communities on diverse hosts, including humans, animals, and plants.
News
News

We actively participate in international probiotic industry seminars and conferences, sharing our research results and industry insights with leading experts and peers around the world.
- Company News
- Industry Insight
About Us
About Us

We are leaders in microbiome research, with a focus on probiotic strains, starter cultures, and the influence of beneficial microbial communities on diverse hosts, including humans, animals, and plants.
Founder
Founder

We actively participate in international probiotic industry seminars and conferences, sharing our research results and industry insights with leading experts and peers around the world.
- Dr. Frank Fang
Contact Us
Contact Us

We welcome the opportunity to connect with you, share more insights, explore potential partnerships, and work together to drive innovation and growth in the probiotic industry.
- Contact Us
- Join Us

English Français Español Русский

Home > Products > WecPost^™ Individual Strains > Bifidobacterium animalis subsp. lactis

Bifidobacterium animalis subsp. lactisBLa80

Potency

100B Cells/g

Source of Strain

Healthy breast milk samples

Deposit Number

PTA-126817(ATCC) No.22547(CGMCC)

Functions

Gastrointestinal Health
Emotional Health
Metabolic Health
Maternal & Child Health
Immune Health
Oral Health

References

[1]Zhao TS, Xie LW, Cai S, Xu JY, Zhou H, Tang LF, Yang C, Fang S, Li M, Tian Y. Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model. Front Cell Infect Microbiol. 2021 Oct 25;11:717636. doi: 10.3389/fcimb.2021.717636. PMID: 34760714; PMCID: PMC8573182.

[2]Dong Y, Liao W, Tang J, Fei T, Gai Z, Han M. Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation. AMB Express. 2022 Jun 7;12(1):67. doi: 10.1186/s13568-022-01411-z. PMID: 35670877; PMCID: PMC9174416.

[3]Dong Y, Han M, Fei T, Liu H, Gai Z. Utilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics. Int Microbiol. 2023 Nov 9. doi: 10.1007/s10123-023-00446-x. Epub ahead of print. PMID: 37946011.

[4]Chen K, Jin S, Ma Y, Cai L, Xu P, Nie Y, Luo L, Yu Q, Shen Y, Zhou Z, Liu C. Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled study. Eur J Clin Nutr. 2024 Mar 11. doi: 10.1038/s41430-024-01428-6. Epub ahead of print. PMID: 38467857.

[5]JanssenDuijghuijsen L, van den Belt M, Rijnaarts I, Vos P, Guillemet D, Witteman B, de Wit N. Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial. Eur J Nutr. 2024 Apr 23. doi: 10.1007/s00394-024-03398-8. Epub ahead of print. PMID: 38653808.

[6]Wu, CaiyunLi, TianlinQi, JingJiang, TianXu, HuaideLei, Hongjie.Effects of lactic acid fermentation-based biotransformation on phenolic profiles, antioxidant capacity and flavor volatiles of apple juice[J].LWT-Food Science & Technology, 2020, 122.

[7]Zhu M, Zhu J, Fang S, Zhao B. Complete Genome Sequence of Bifidobacterium animalis subsp. lactis BLa80, a Strain Isolated from Human Breast Milk. Microbiol Resour Announc. 2023 Jun 20;12(6):e0046522. doi: 10.1128/mra.00465-22. Epub 2023 May 22. PMID: 37212697; PMCID: PMC10281126.

Specialization Advantages